Skip to content
← Back to this collection

PUBLICATIONS · 23403817

Ridaforolimus as a single agent in advanced endometrial cancer: results of a single-arm, phase 2 trial.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Br J Cancer
Publication date
2013 Mar 19
First author
Colombo N

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Colombo N
      type
      Author
    2. name
      McMeekin DS
      type
      Author
    3. name
      Schwartz PE
      type
      Author
    4. name
      Sessa C
      type
      Author
    5. name
      Gehrig PA
      type
      Author
    6. name
      Holloway R
      type
      Author
    7. name
      Braly P
      type
      Author
    8. name
      Matei D
      type
      Author
    9. name
      Morosky A
      type
      Author
    10. name
      Dodion PF
      type
      Author
    11. name
      Einstein MH
      type
      Author
    12. name
      Haluska F
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      Colombo N
      type
      Author
    2. name
      McMeekin DS
      type
      Author
    3. name
      Schwartz PE
      type
      Author
    4. name
      Sessa C
      type
      Author
    5. name
      Gehrig PA
      type
      Author
    6. name
      Holloway R
      type
      Author
    7. name
      Braly P
      type
      Author
    8. name
      Matei D
      type
      Author
    9. name
      Morosky A
      type
      Author
    10. name
      Dodion PF
      type
      Author
    11. name
      Einstein MH
      type
      Author
    12. name
      Haluska F
      type
      Author
    bibliography ids
    1. nci-bib-d986b056d487b2708ddc2f49
    book metadata
    content sha256
    6adca0d80ea96a3b27385cef176a8ed25fc677e8b2c935d5a00f7dd505a309d0
    document type
    citation
    dois
    1. 10.1038/bjc.2013.59
    electronic publication date
    display
    2013 Feb 12
    precision
    day
    year
    2013
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:23403817
    immutable id
    pubmed:23403817@6adca0d80ea96a3b27385cef176a8ed25fc677e8b2c935d5a00f7dd505a309d0
    journal
    abbreviation
    Br J Cancer
    issn electronic
    1532-1827
    issn print
    0007-0920
    issue
    5
    name
    British journal of cancer
    nlm unique id
    0370635
    pages
    1021-6
    volume
    108
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      23403817
      provenance
      batch id
      99e008dabc339d38fd44
      provider
      NCBI PubMed ESummary
      record sha256
      ef10a10eb3afe5a7fe4cf9b9e53f091f0156e1c0fbc80d6155f72bcd410d6580
      response sha256
      804916232567480946eda9a00aff276bc44fd9a6d15d9336e773a9c803123d39
      retrieved at
      2026-09-09T23:46:55.094762+00:00
      publication date
      display
      2013 Mar 19
      precision
      day
      year
      2013
      publication types
      1. Clinical Trial, Phase II
      2. Journal Article
      3. Multicenter Study
      4. Research Support, Non-U.S. Gov't
      record status
      PubMed - indexed for MEDLINE
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/23403817/
      title
      Ridaforolimus as a single agent in advanced endometrial cancer: results of a single-arm, phase 2 trial.

      Preserved source evidence · Not medical advice